Skip to content

Three Key Voices in the Medical Marijuana Industry

Three Key Voices in the Medical Marijuana Industry

As medical marijuana programs continue to expand throughout the United States, it is important to recognize some of the key voices throughout the industry that got us here. These individuals range from researches to physicians and even to patients who started their own advocacy group. Keep reading to learn about just three of the many key voices that have helped push medical cannabis to where it is today.

Steph Sherer

In 2002, Steph Sherer founded Americans for Safe Access, a member-based non-profit organization that advocates on behalf of patients to establish and expand safe and legal access to medical cannabis. The organization is made up of patients, medical professionals, scientists and citizens who are all interested in promoting cannabis for research and medicinal use. The organization currently boasts over 100,000 active members across the nation, making it the leading advocacy group for medical cannabis policy reform.

Steph’s advocacy for medical use of cannabis began through her own experience with chronic pain. Before developing this condition, Sherer was not aware of the potential health benefits medical cannabis could have for her condition and many others’. Since discovering this potentially life changing alternative treatment, she has dedicated her career to spreading awareness of the health benefits medical marijuana can bring along with expanding safe and legal access to it for patients and researchers alike.

Dr. Prakash Nagarkatti

As the Vice President for Research and a distinguished professor at the University of South Carolina, Dr. Prakash Nagarkatti is known as a key voice in the medical marijuana industry. For the past 20 years, Nagarkatti has been one of the leading researchers into medicinal uses for cannabis.  In early 2019, a study performed by Dr. Prakash Nagarkatti led to the FDA approving the use of CBD to treat autoimmune hepatitis. This study, along with many others, was a huge success for medical marijuana research and the fight against FDA’s strict regulations.

Along with conducting his own research, Dr. Nagarkatti is also a strong advocate for the general expansion of research and clinical trials of medical marijuana. The strict classification on marijuana imposes strong limitations on labs for performing this important research. Fortunately, Dr. Nagarkatti’s lab is one of the only labs in the nation that is licensed to perform research on cannabinoid compounds. Dr. Prakash Nagarkatti will remain a key voice in medical marijuana industry as he continues to stretch the bounds in terms of research and advocacy.

Dr. Sanjay Gupta

Dr. Sanjay Gupta is a practicing neurosurgeon as well as the chief medical correspondent for CNN, for which he is a multiple Emmy® winner. In this role, he is the key reporter on all health and medical news across all CNN shows. He is also the host of Vital Signs and the CNN original series “Chasing Life with Dr. Sanjay Gupta”. Since 2001, Dr. Gupta has been covering the most important stories in the health industry, establishing him as a key voice that people listen to and trust for their medical news.

In 2013, Gupta began to travel in order to gain insight on the medical marijuana industry through interviewing medical leaders, experts and patients. After going on the journey, Dr. Gupta detailed what he learned through this experience and why he has become a leading advocate for medical cannabis in his four-part series on CNN titled ‘Weed’. Each installment of the series explores a different piece of the medical cannabis industry and has become groundbreaking in educating viewers on the mysterious plant and the widespread medicinal benefits it can bring.

For many of these voices, they were not advocating for the alternative treatment until they conducted more research. After seeing the proof and efficacies, they jumped on board and became the key voices that many Americans trust and listen to. At Arfinn Med, we are aiming to educate physicians and patients alike of the potential benefits that medical marijuana can bring.

If you’re interested in exploring medical marijuana treatments for your patients, join Arfinn Med for FREE today! Through our portal, you will be able to gain access to peer-to-peer data on medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings.

Sources:

https://www.forbes.com/sites/benjaminsetiawan/2019/04/30/steph-sherer-president-of-icci-makes-the-case-for-medical-cannabis-part-1/#4cff3a073f0a

https://www.thestate.com/news/special-reports/article225993350.html

https://www.cnn.com/profiles/sanjay-gupta-profile#about

https://www.cnn.com/2013/08/08/health/gupta-changed-mind-marijuana/index.html

Stories you may be interested in

Minnesota study finds that medical pot soothes cancer pains

Symptoms such as pain and nausea improved in cancer patients who took cannabis, according to new research that is part of Minnesota’s effort to address the information void about whether marijuana offers medical benefits. Analyzing 1,120 cancer patients who received cannabis through the state medical marijuana program, researchers reported Monday that they found noteworthy improvements…
Read More

Medical Marijuana Faces Acceptance Barrier by Hesitant Medical Schools

A new study shows a growing interest by university pharmacy programs in teaching about medical marijuana in their curriculum, while medical schools seem to lag behind. Sixty-two percent of U.S. pharmacy school respondents queried in a new survey said they included medical marijuana in their doctorate of pharmacy curriculum. That’s according to a nine-page study co-authored by…
Read More

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

Research shows cannabis can lower opioid dosage, but studies are preliminary

Larson cited one statistic to justify his bill: “Studies have shown up to 75% reduction in opioid dosage for medical cannabis users” The intersection of medical cannabis and opioid use as treatments for chronic pain is an emerging field of research as more states loosen regulations on medical and recreational use of marijuana. But does…
Read More

Medical Marijuana a Hit With Seniors

In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opioid painkillers. Nine out of 10 liked it so much they said they’d recommend medical pot to others. “I was on Percocet and replaced it with medical marijuana. Thank you, thank you, thank you,” said one senior. Another patient put…
Read More

Arfinn Med Patient Site

We get a lot of interest from patients asking about efficacy data for medical marijuana on a number of conditions. Though we are primarily an electronic medical record (EMR) company focussing on the cannabis industry and other complimentary or alternative therapies, our primary focus is better quality care for patients. So with that being said,…
Read More

Leave a Comment

You must be logged in to post a comment.